With an eye on the rising number of tech-savvy patients and health care personnel (HCP) relying on digital information, Lupin Ltd. has partnered with Aptar Pharma to introduce India’s first smart device for metered-dose inhalers (MDIs). The device brand name, Adhero, plays on its intended end-benefit of adherence to therapy among those with chronic respiratory diseases.
Inhalers are the preferred delivery option for managing a rising incidence of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) in India
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?